<p>Verition Fund Management LLC 在最近向證券交易委員會（SEC）提交的 13F 表格中表示，在第三季度將其在 Alignment Healthcare, Inc. (NASDAQ:ALHC - 免費報告) 的持股比例提高了 85.3%。該公司在本季度額外購買了 55,771 股後，持有該公司 121,180 股股票。Verition Fund Management LLC 在最近的報告期末持有的 Alignment Healthcare 約佔 0.06%，價值 1,432,000 美元。</p>
<p>獲取 <strong>Alignment Healthcare</strong> 警報：</p>
<p>其他一些機構投資者最近也對其在 ALHC 的持倉進行了調整。Deerfield Management Company L.P. Series C 在第二季度將其在 Alignment Healthcare 的股份提高了 31.8%。Deerfield Management Company L.P. Series C 目前持有 10,901,485 股該公司的股票，價值 85,250,000 美元，在此期間又收購了 2,630,788 股。Hood River Capital Management LLC 在第二季度將其在 Alignment Healthcare 的股份提高了 6.4%。Hood River Capital Management LLC 目前持有 3,106,690 股該公司的股票，價值 24,294,000 美元，在此期間又購買了 185,854 股。William Blair Investment Management LLC 在第二季度將其在 Alignment Healthcare 的股份提高了 94.4%。William Blair Investment Management LLC 目前持有 3,104,681 股該公司的股票，價值 24,279,000 美元，在上個季度又購買了 1,507,759 股。Renaissance Technologies LLC 在第二季度將其在 Alignment Healthcare 的持股提高了 16.8%。Renaissance Technologies LLC 目前持有 1,565,800 股該公司的股票，價值 12,245,000 美元，在此期間又購買了 225,000 股。最後，Charles Schwab Investment Management Inc. 在第三季度將其在 Alignment Healthcare 的股份提高了 1.7%。Charles Schwab Investment Management Inc. 目前持有 839,695 股該公司的股票，價值 9,925,000 美元，在上個季度又購買了 13,865 股。對沖基金和其他機構投資者持有該公司 86.19% 的股票。</p>
<h2>Alignment Healthcare 價格表現</h2>
<p>NASDAQ:ALHC 的股票在週五開盤價為 11.39 美元。該公司的 50 日移動平均價格為 11.93 美元，200 日移動平均價格為 9.91 美元。該公司的債務與股本比率為 1.82，流動比率為 1.60，速動比率為 1.60。該公司的市值為 21.8 億美元，市盈率為 -15.84，貝塔值為 1.42。Alignment Healthcare, Inc. 的一年最低價為 4.46 美元，一年最高價為 14.25 美元。</p>
<p>Alignment Healthcare (NASDAQ:ALHC - 獲取免費報告) 最近於 10 月 29 日（星期二）發佈了其財報。該公司報告本季度每股收益為（0.14 美元），符合分析師的共識預期（0.14 美元）。Alignment Healthcare 的股本回報率為 -108.69%，淨利潤率為 -5.84%。該公司本季度的收入為 6.9243 億美元，而分析師預期為 6.6211 億美元。在去年同期，該公司每股收益為（0.19 美元）。該公司的收入同比增長 51.6%。平均而言，股票研究分析師預計 Alignment Healthcare, Inc. 本財年每股收益將為 -0.69 美元。</p>
<h2>Alignment Healthcare 的內部買賣</h2>
<p>在其他 Alignment Healthcare 的新聞中，首席財務官 Robert Thomas Freeman 於 9 月 11 日（星期三）出售了 8,561 股該公司的股票。股票以平均價格 10.01 美元出售，總價值為 85,695.61 美元。出售完成後，首席財務官現在直接持有 399,429 股該公司的股票，價值 3,998,284.29 美元。此次交易使其持股減少了 2.10%。該交易已在向 SEC 提交的文件中披露，文件可在 SEC 網站上查閲。此外，董事 Joseph S. Konowiecki 於 11 月 11 日（星期一）出售了 6,920 股該公司的股票。股票以平均價格 13.73 美元出售，總價值為 95,011.60 美元。交易完成後，該董事現在直接持有 1,134,888 股該公司的股票，價值 15,582,012.24 美元。此次交易使其持股減少了 0.61%。該銷售的披露信息可以在這裏找到。過去九十天內，內部人士已出售 603,057 股公司股票，價值 7,276,931 美元。內部人士持有該公司 6.60% 的股票。</p>
<h2>華爾街分析師預測增長</h2>
<p>ALHC 已成為多份分析師報告的主題。Robert W. Baird 在 8 月 14 日（星期三）的報告中將 Alignment Healthcare 的目標價從 10.00 美元上調至 11.00 美元，並給予該股票 &#34;跑贏大盤&#34; 的評級。KeyCorp 在 10 月 11 日（星期五）的研究報告中開始覆蓋 Alignment Healthcare。他們對該公司的評級為 &#34;行業權重&#34;。Stephens 將 Alignment Healthcare 的評級從 &#34;持平&#34; 上調至 &#34;增持&#34;，並在週二將該公司的目標價從 13.00 美元上調至 17.00 美元。瑞銀集團在 10 月 30 日（星期三）的研究報告中將 Alignment Healthcare 的目標價從 9.00 美元上調至 12.00 美元，並給予該公司 &#34;中性&#34; 的評級。最後，巴克萊在 10 月 30 日（星期三）的研究報告中將 Alignment Healthcare 的目標價從 7.00 美元上調至 8.00 美元，並給予該公司 &#34;減持&#34; 的評級。一位研究分析師對該股票給予了賣出評級，兩位分析師給予了持有評級，七位分析師給予了買入評級，兩位分析師給予了強烈買入評級。根據 MarketBeat 的數據，Alignment Healthcare 目前的共識評級為 &#34;適度買入&#34;，共識目標價為 11.44 美元。</p>
<p><strong>查看我們最新的 ALHC 股票報告</strong></p>
<h2>Alignment Healthcare 簡介</h2>
<p>（免費報告）</p>
<p>Alignment Healthcare, Inc.是一家技術驅動的醫療保險優勢公司，為美國老年人提供以消費者為中心的醫療保健平台。它通過醫療保險優勢計劃提供定製的醫療保健，以滿足多樣化老年人的需求。該公司成立於 2013 年，總部位於加利福尼亞州橙縣。</p>
<h2>精選文章</h2>
<ul>
<li>五隻我們認為比 Alignment Healthcare 更好的股票</li>
<li>在 52 周高點盈利交易股票</li>
<li>Trinity Capital 首席執行官談私募信貸的高收益增長</li>
<li>什麼是二次公開募股？投資者需要知道什麼</li>
<li>Lululemon 在第三季度報告中大幅上漲：分析師介入支持市場</li>
<li>什麼是內幕交易？你可以從內幕交易中學到什麼</li>
<li>10 個安全的高回報投資</li>
</ul>
<p><strong>想看看其他對 ALHC 持有的對沖基金嗎？</strong> 請訪問 HoldingsChannel.com，獲取 Alignment Healthcare, Inc.（NASDAQ:ALHC - 免費報告）的最新 13F 文件和內幕交易。</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9QUxIQw?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9QUxIQw"/></p>
<p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快和最準確的報道。此故事在發佈前已由 MarketBeat 的編輯團隊審核。如對該故事有任何問題或意見，請發送至 contact@marketbeat.com。</em></p>
<p>→ 埃隆·馬斯克對人類的驚人警告（來自自由港協會）（廣告）</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD0xMDY2Nw?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD0xMDY2Nw"/></p>
<h2>你現在應該投資 1,000 美元在 Alignment Healthcare 嗎？</h2>
<p>在考慮 Alignment Healthcare 之前，你需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師悄悄向客户推薦的股票，建議在更廣泛的市場注意到之前購買……而 Alignment Healthcare 並不在名單上。</p>
<p>雖然 Alignment Healthcare 目前在分析師中獲得了 “適度買入” 的評級，但頂級分析師認為這五隻股票更值得購買。</p>
<p>在這裏查看這五隻股票</p>

ALHC

<p>Verition Fund Management LLC 在第三季度將其在 Alignment Healthcare, Inc. (NASDAQ:ALHC) 的持股增加了 85.3%，收購了 55,771 股，使其總持股達到 121,180 股，價值約為 1,432,000 美元。其他機構投資者也增加了在 ALHC 的持倉。該公司的股票開盤價為 0.39 美元，市值為 11.8 億美元。Alignment Healthcare 報告稱，收入同比增長 51.6%，上個季度每股收益為 -0.14，符合分析師的預期。在過去 90 天內，內部人士共出售了 603,057 股</p>

<p>Verition Fund Management LLC raised its position in Alignment Healthcare, Inc. (NASDAQ:ALHC - Free Report) by 85.3% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 121,180 shares of the company's stock after buying an additional 55,771 shares during the quarter. Verition Fund Management LLC owned about 0.06% of Alignment Healthcare worth $1,432,000 at the end of the most recent reporting period.</p>
<div class="lb-trans"><p>Verition Fund Management LLC 在最近向證券交易委員會（SEC）提交的 13F 表格中表示，在第三季度將其在 Alignment Healthcare, Inc. (NASDAQ:ALHC - 免費報告) 的持股比例提高了 85.3%。該公司在本季度額外購買了 55,771 股後，持有該公司 121,180 股股票。Verition Fund Management LLC 在最近的報告期末持有的 Alignment Healthcare 約佔 0.06%，價值 1,432,000 美元。</p>
</div><p>Get <strong>Alignment Healthcare</strong> alerts:</p>
<div class="lb-trans"><p>獲取 <strong>Alignment Healthcare</strong> 警報：</p>
</div><p>A number of other institutional investors have also recently made changes to their positions in ALHC. Deerfield Management Company L.P. Series C raised its stake in Alignment Healthcare by 31.8% in the 2nd quarter. Deerfield Management Company L.P. Series C now owns 10,901,485 shares of the company's stock valued at $85,250,000 after acquiring an additional 2,630,788 shares during the period. Hood River Capital Management LLC raised its position in shares of Alignment Healthcare by 6.4% in the second quarter. Hood River Capital Management LLC now owns 3,106,690 shares of the company's stock valued at $24,294,000 after purchasing an additional 185,854 shares during the period. William Blair Investment Management LLC lifted its stake in shares of Alignment Healthcare by 94.4% during the 2nd quarter. William Blair Investment Management LLC now owns 3,104,681 shares of the company's stock valued at $24,279,000 after buying an additional 1,507,759 shares in the last quarter. Renaissance Technologies LLC boosted its holdings in Alignment Healthcare by 16.8% in the 2nd quarter. Renaissance Technologies LLC now owns 1,565,800 shares of the company's stock worth $12,245,000 after buying an additional 225,000 shares during the period. Finally, Charles Schwab Investment Management Inc. grew its stake in Alignment Healthcare by 1.7% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 839,695 shares of the company's stock valued at $9,925,000 after buying an additional 13,865 shares in the last quarter. Hedge funds and other institutional investors own 86.19% of the company's stock.</p>
<div class="lb-trans"><p>其他一些機構投資者最近也對其在 ALHC 的持倉進行了調整。Deerfield Management Company L.P. Series C 在第二季度將其在 Alignment Healthcare 的股份提高了 31.8%。Deerfield Management Company L.P. Series C 目前持有 10,901,485 股該公司的股票，價值 85,250,000 美元，在此期間又收購了 2,630,788 股。Hood River Capital Management LLC 在第二季度將其在 Alignment Healthcare 的股份提高了 6.4%。Hood River Capital Management LLC 目前持有 3,106,690 股該公司的股票，價值 24,294,000 美元，在此期間又購買了 185,854 股。William Blair Investment Management LLC 在第二季度將其在 Alignment Healthcare 的股份提高了 94.4%。William Blair Investment Management LLC 目前持有 3,104,681 股該公司的股票，價值 24,279,000 美元，在上個季度又購買了 1,507,759 股。Renaissance Technologies LLC 在第二季度將其在 Alignment Healthcare 的持股提高了 16.8%。Renaissance Technologies LLC 目前持有 1,565,800 股該公司的股票，價值 12,245,000 美元，在此期間又購買了 225,000 股。最後，Charles Schwab Investment Management Inc. 在第三季度將其在 Alignment Healthcare 的股份提高了 1.7%。Charles Schwab Investment Management Inc. 目前持有 839,695 股該公司的股票，價值 9,925,000 美元，在上個季度又購買了 13,865 股。對沖基金和其他機構投資者持有該公司 86.19% 的股票。</p>
</div><h2>Alignment Healthcare Price Performance</h2>
<div class="lb-trans"><h2>Alignment Healthcare 價格表現</h2>
</div><p>Shares of NASDAQ:ALHC opened at $11.39 on Friday. The company's fifty day moving average price is $11.93 and its 200-day moving average price is $9.91. The company has a debt-to-equity ratio of 1.82, a current ratio of 1.60 and a quick ratio of 1.60. The firm has a market capitalization of $2.18 billion, a price-to-earnings ratio of -15.84 and a beta of 1.42. Alignment Healthcare, Inc. has a one year low of $4.46 and a one year high of $14.25.</p>
<div class="lb-trans"><p>NASDAQ:ALHC 的股票在週五開盤價為 11.39 美元。該公司的 50 日移動平均價格為 11.93 美元，200 日移動平均價格為 9.91 美元。該公司的債務與股本比率為 1.82，流動比率為 1.60，速動比率為 1.60。該公司的市值為 21.8 億美元，市盈率為 -15.84，貝塔值為 1.42。Alignment Healthcare, Inc. 的一年最低價為 4.46 美元，一年最高價為 14.25 美元。</p>
</div><p>Alignment Healthcare (NASDAQ:ALHC - Get Free Report) last released its earnings results on Tuesday, October 29th. The company reported ($0.14) EPS for the quarter, meeting analysts' consensus estimates of ($0.14). Alignment Healthcare had a negative return on equity of 108.69% and a negative net margin of 5.84%. The business had revenue of $692.43 million for the quarter, compared to analysts' expectations of $662.11 million. During the same quarter in the prior year, the firm earned ($0.19) earnings per share. The firm's revenue was up 51.6% on a year-over-year basis. On average, equities research analysts anticipate that Alignment Healthcare, Inc. will post -0.69 earnings per share for the current fiscal year.</p>
<div class="lb-trans"><p>Alignment Healthcare (NASDAQ:ALHC - 獲取免費報告) 最近於 10 月 29 日（星期二）發佈了其財報。該公司報告本季度每股收益為（0.14 美元），符合分析師的共識預期（0.14 美元）。Alignment Healthcare 的股本回報率為 -108.69%，淨利潤率為 -5.84%。該公司本季度的收入為 6.9243 億美元，而分析師預期為 6.6211 億美元。在去年同期，該公司每股收益為（0.19 美元）。該公司的收入同比增長 51.6%。平均而言，股票研究分析師預計 Alignment Healthcare, Inc. 本財年每股收益將為 -0.69 美元。</p>
</div><h2>Insider Buying and Selling at Alignment Healthcare</h2>
<div class="lb-trans"><h2>Alignment Healthcare 的內部買賣</h2>
</div><p>In other Alignment Healthcare news, CFO Robert Thomas Freeman sold 8,561 shares of the business's stock in a transaction on Wednesday, September 11th. The shares were sold at an average price of $10.01, for a total value of $85,695.61. Following the completion of the sale, the chief financial officer now directly owns 399,429 shares of the company's stock, valued at $3,998,284.29. The trade was a 2.10 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Director Joseph S. Konowiecki sold 6,920 shares of the firm's stock in a transaction dated Monday, November 11th. The shares were sold at an average price of $13.73, for a total value of $95,011.60. Following the transaction, the director now directly owns 1,134,888 shares in the company, valued at $15,582,012.24. This trade represents a 0.61 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 603,057 shares of company stock worth $7,276,931 over the last ninety days. Insiders own 6.60% of the company's stock.</p>
<div class="lb-trans"><p>在其他 Alignment Healthcare 的新聞中，首席財務官 Robert Thomas Freeman 於 9 月 11 日（星期三）出售了 8,561 股該公司的股票。股票以平均價格 10.01 美元出售，總價值為 85,695.61 美元。出售完成後，首席財務官現在直接持有 399,429 股該公司的股票，價值 3,998,284.29 美元。此次交易使其持股減少了 2.10%。該交易已在向 SEC 提交的文件中披露，文件可在 SEC 網站上查閲。此外，董事 Joseph S. Konowiecki 於 11 月 11 日（星期一）出售了 6,920 股該公司的股票。股票以平均價格 13.73 美元出售，總價值為 95,011.60 美元。交易完成後，該董事現在直接持有 1,134,888 股該公司的股票，價值 15,582,012.24 美元。此次交易使其持股減少了 0.61%。該銷售的披露信息可以在這裏找到。過去九十天內，內部人士已出售 603,057 股公司股票，價值 7,276,931 美元。內部人士持有該公司 6.60% 的股票。</p>
</div><h2>Wall Street Analysts Forecast Growth</h2>
<div class="lb-trans"><h2>華爾街分析師預測增長</h2>
</div><p>ALHC has been the subject of a number of analyst reports. Robert W. Baird raised their price target on Alignment Healthcare from $10.00 to $11.00 and gave the stock an &#34;outperform&#34; rating in a report on Wednesday, August 14th. KeyCorp assumed coverage on Alignment Healthcare in a research note on Friday, October 11th. They issued a &#34;sector weight&#34; rating for the company. Stephens upgraded Alignment Healthcare from an &#34;equal weight&#34; rating to an &#34;overweight&#34; rating and upped their price target for the company from $13.00 to $17.00 in a research report on Tuesday. UBS Group raised their price objective on shares of Alignment Healthcare from $9.00 to $12.00 and gave the company a &#34;neutral&#34; rating in a research report on Wednesday, October 30th. Finally, Barclays boosted their price objective on shares of Alignment Healthcare from $7.00 to $8.00 and gave the company an &#34;underweight&#34; rating in a research note on Wednesday, October 30th. One research analyst has rated the stock with a sell rating, two have issued a hold rating, seven have given a buy rating and two have assigned a strong buy rating to the stock. Based on data from MarketBeat, Alignment Healthcare presently has a consensus rating of &#34;Moderate Buy&#34; and a consensus price target of $11.44.</p>
<div class="lb-trans"><p>ALHC 已成為多份分析師報告的主題。Robert W. Baird 在 8 月 14 日（星期三）的報告中將 Alignment Healthcare 的目標價從 10.00 美元上調至 11.00 美元，並給予該股票 &#34;跑贏大盤&#34; 的評級。KeyCorp 在 10 月 11 日（星期五）的研究報告中開始覆蓋 Alignment Healthcare。他們對該公司的評級為 &#34;行業權重&#34;。Stephens 將 Alignment Healthcare 的評級從 &#34;持平&#34; 上調至 &#34;增持&#34;，並在週二將該公司的目標價從 13.00 美元上調至 17.00 美元。瑞銀集團在 10 月 30 日（星期三）的研究報告中將 Alignment Healthcare 的目標價從 9.00 美元上調至 12.00 美元，並給予該公司 &#34;中性&#34; 的評級。最後，巴克萊在 10 月 30 日（星期三）的研究報告中將 Alignment Healthcare 的目標價從 7.00 美元上調至 8.00 美元，並給予該公司 &#34;減持&#34; 的評級。一位研究分析師對該股票給予了賣出評級，兩位分析師給予了持有評級，七位分析師給予了買入評級，兩位分析師給予了強烈買入評級。根據 MarketBeat 的數據，Alignment Healthcare 目前的共識評級為 &#34;適度買入&#34;，共識目標價為 11.44 美元。</p>
</div><p><strong>Check Out Our Latest Stock Report on ALHC</strong></p>
<div class="lb-trans"><p><strong>查看我們最新的 ALHC 股票報告</strong></p>
</div><h2>Alignment Healthcare Profile</h2>
<div class="lb-trans"><h2>Alignment Healthcare 簡介</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>（免費報告）</p>
</div><p>Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.</p>
<div class="lb-trans"><p>Alignment Healthcare, Inc.是一家技術驅動的醫療保險優勢公司，為美國老年人提供以消費者為中心的醫療保健平台。它通過醫療保險優勢計劃提供定製的醫療保健，以滿足多樣化老年人的需求。該公司成立於 2013 年，總部位於加利福尼亞州橙縣。</p>
</div><h2>Featured Articles</h2>
<div class="lb-trans"><h2>精選文章</h2>
</div><ul>
<li>Five stocks we like better than Alignment Healthcare</li>
<li>Profitably Trade Stocks at 52-Week Highs</li>
<li>Trinity Capital CEO on Leading Private Credit’s High-Yield Growth</li>
<li>What is a Secondary Public Offering? What Investors Need to Know</li>
<li>Lululemon Surges On Q3 Report: Analysts Step in To Support Market</li>
<li>What is Insider Trading? What You Can Learn from Insider Trading</li>
<li>10 Safe Investments with High Returns</li>
</ul>
<div class="lb-trans"><ul>
<li>五隻我們認為比 Alignment Healthcare 更好的股票</li>
<li>在 52 周高點盈利交易股票</li>
<li>Trinity Capital 首席執行官談私募信貸的高收益增長</li>
<li>什麼是二次公開募股？投資者需要知道什麼</li>
<li>Lululemon 在第三季度報告中大幅上漲：分析師介入支持市場</li>
<li>什麼是內幕交易？你可以從內幕交易中學到什麼</li>
<li>10 個安全的高回報投資</li>
</ul>
</div><p><strong>Want to see what other hedge funds are holding ALHC?</strong> Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Alignment Healthcare, Inc. (NASDAQ:ALHC - Free Report).</p>
<div class="lb-trans"><p><strong>想看看其他對 ALHC 持有的對沖基金嗎？</strong> 請訪問 HoldingsChannel.com，獲取 Alignment Healthcare, Inc.（NASDAQ:ALHC - 免費報告）的最新 13F 文件和內幕交易。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9QUxIQw" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NASDAQ&amp;Symbol=ALHC"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快和最準確的報道。此故事在發佈前已由 MarketBeat 的編輯團隊審核。如對該故事有任何問題或意見，請發送至 contact@marketbeat.com。</em></p>
</div><p>→ Elon Musk’s chilling warning for humanity (From The Freeport Society)(Ad)</p>
<div class="lb-trans"><p>→ 埃隆·馬斯克對人類的驚人警告（來自自由港協會）（廣告）</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD0xMDY2Nw" alt="" original-src="https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx?TriggeredCampaignID=10667&amp;Placement=NativeDisplay&amp;Source=NativeDisplay"/></p>
<h2>Should you invest $1,000 in Alignment Healthcare right now?</h2>
<div class="lb-trans"><h2>你現在應該投資 1,000 美元在 Alignment Healthcare 嗎？</h2>
</div><p>Before you consider Alignment Healthcare, you'll want to hear this.</p>
<div class="lb-trans"><p>在考慮 Alignment Healthcare 之前，你需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Alignment Healthcare wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師悄悄向客户推薦的股票，建議在更廣泛的市場注意到之前購買……而 Alignment Healthcare 並不在名單上。</p>
</div><p>While Alignment Healthcare currently has a &#34;Moderate Buy&#34; rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然 Alignment Healthcare 目前在分析師中獲得了 “適度買入” 的評級，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在這裏查看這五隻股票</p>
</div>

Verition Fund Management LLC Purchases 55,771 Shares of Alignment Healthcare, Inc. (NASDAQ:ALHC)

Verition Fund Management LLC 購買了 Alignment Healthcare, Inc.（納斯達克股票代碼：ALHC）的 55,771 股股票